Tyrosine phosphorylation of maspin in normal mammary epithelia and breast cancer cells.

Biochem Biophys Res Commun

Department of Anatomy and Cell Biology, The Roy J. and Lucille A. Carver College of Medicine, The University of Iowa, Iowa City, IA 52242, USA.

Published: July 2002

Maspin is a 42kDa tumor suppressor protein that belongs to the serine protease inhibitor (serpin) family. It inhibits cell motility and invasion in vitro, and tumor growth and metastasis in nude mice; however, maspin's molecular mechanism of action has remained elusive. Maspin contains several tyrosine residues and we hypothesized that phosphorylation of maspin could play a role in its biological function. Our study reveals that maspin is phosphorylated on tyrosine moiety(ies) in normal mammary epithelial cells endogenously expressing maspin. In addition, transfection of the maspin gene, using either a stable or inducible system into maspin-deficient breast cancer cell lines, yields a protein product that is phosphorylated on tyrosine residue(s). Furthermore, recombinant maspin protein can be tyrosine-phosphorylated by the kinase domain from the epidermal growth factor receptor in vitro. These novel observations suggest that maspin, which deviates from the classical serpin, may be an important signal transduction molecule in its phosphorylated form.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0006-291x(02)00764-7DOI Listing

Publication Analysis

Top Keywords

maspin
9
phosphorylation maspin
8
normal mammary
8
breast cancer
8
tyrosine residues
8
phosphorylated tyrosine
8
tyrosine
4
tyrosine phosphorylation
4
maspin normal
4
mammary epithelia
4

Similar Publications

Mammary serine protease inhibitor (maspin) is a tumor suppressor protein downregulated during carcinogenesis and cancer progression; cytoplasmic-only maspin expression is an independent, unfavorable prognostic indicator in patients with lung squamous cell carcinoma (LUSC). We hypothesized that the cytoplasmic-only localization of maspin has tumor-promoting functions in LUSC. The subcellular localization of maspin and the invasive capability of LUSC cell lines were investigated using RNA sequencing (RNA-seq), Western blotting, and siRNA transfection.

View Article and Find Full Text PDF

Application of urine proteomics in the diagnosis and treatment effectiveness monitoring of early-stage Mycosis Fungoides.

Clin Proteomics

August 2024

Department of Dermatology, Peking Union Medical College Hospital, State Key Laboratory of Complex Severe and Rare Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases, Dongcheng District, Beijing, 100730, China.

Article Synopsis
  • Mycosis fungoides (MF) is a common skin lymphoma often misdiagnosed due to its non-specific early symptoms, leading to treatment delays; researchers aimed to find urinary biomarkers for early detection of MF through proteomic analysis.
  • A study involving 13 early-stage MF patients treated with interferon α-2a and phototherapy analyzed urine samples before and after treatment, comparing them with healthy controls to identify differentially expressed proteins.
  • The results revealed 41 proteins with significant expression changes, with certain proteins like Serpin B5, epidermal growth factor (EGF), and RhoA showing lower levels in untreated MF patients, but these levels normalized after treatment, indicating potential biomarkers for monitoring MF.
View Article and Find Full Text PDF

Background: Colorectal cancer remains to be the third leading cause of cancer mortality rates. Despite the diverse effects of the miRNA cluster located in of 8q24.21 across various tumors, the specific biological function in colorectal cancer has not been clarified.

View Article and Find Full Text PDF

Prognostic value of Maspin protein level in patients with triple negative breast cancer.

Sci Rep

July 2024

Center for Translational Research in Oncology, Cancer Institute of the State of São Paulo (ICESP), Clinical Hospital Faculty of Medicine, University of São Paulo (HCFMUSP), São Paulo, SP, 01246-000, Brazil.

The search for prognostic markers in breast cancer has bumped into a typical feature of these tumors, intra and intertumoral heterogeneity. Changes in the expression profile, localization of these proteins or shedding to the surrounding stroma can be useful in the search for new markers. In this context, classification by molecular subtypes can bring perspectives for both diagnosis and screening for appropriate treatments.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!